Literature DB >> 8880503

Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes.

E L Wright1, S Zywno-van Ginkel, N Rastogi, W W Barrow.   

Abstract

Recent reports indicate that polyclonal infections may play an important role in multiple drug resistance in Mycobacterium avium infections. We report here on the isolation of a single M. avium strain that appeared to have smooth colony morphology upon initial isolation on a Lowenstein-Jensen slant. Primary subculture onto Middlebrook 7H10, however, revealed three distinct morphotypes representing smooth opaque (SmO), smooth transparent (SmT), and rough (Rg) colony morphologies. All three morphotypes were identified as M. avium by standard biochemical procedures, Genprobe analysis, and mycolic acid patterns. Subsequent restriction fragment length polymorphism analysis, using SalI- and PvuII-digested genomic DNA, revealed identical patterns for hybridization with the IS1245 probe. Thin-layer chromatographic analysis of lipids from the three morphotypes revealed that only the SmT morphotype possessed what appeared to be lipid components similar to, but unlike, previously described serovar-specific glycopeptidolipid antigens. Further analysis of internally radiolabeled deacylated lipids from the SmT morphotype, by high-performance liquid chromatography and thin-layer chromatography, disclosed that some of these components can be internally radiolabeled with [14C] phenylalanine and [14C]mannose. These results suggest that these components are structurally similar to previously described glycopeptidolipid antigens. This is apparently the first report of a monoclonal infection involving a single strain of M. avium presenting with all three colony morphotypes, SmO, SmT, and Rg.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880503      PMCID: PMC229297          DOI: 10.1128/jcm.34.10.2475-2478.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Description of various colony forms of mycobacteria.

Authors:  G B FREGNAN; D W SMITH
Journal:  J Bacteriol       Date:  1962-04       Impact factor: 3.490

Review 2.  Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.

Authors:  J J Ellner; M J Goldberger; D M Parenti
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Structure and functions of the cell envelope in relation to mycobacterial virulence, pathogenicity and multiple drug resistance. 7th Forum in Microbiology.

Authors: 
Journal:  Res Microbiol       Date:  1991-05       Impact factor: 3.992

4.  Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens.

Authors:  W W Barrow; P J Brennan
Journal:  J Bacteriol       Date:  1982-04       Impact factor: 3.490

5.  Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.

Authors:  W W Barrow; T L Davis; E L Wright; V Labrousse; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

Authors:  W W Barrow; E L Wright; K S Goh; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 7.  Tuberculosis in patients with HIV infection.

Authors:  P F Barnes; H Q Le; P T Davidson
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

8.  Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates.

Authors:  A M Slutsky; R D Arbeit; T W Barber; J Rich; C F von Reyn; W Pieciak; M A Barlow; J N Maslow
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose.

Authors:  E L Wright; W W Barrow
Journal:  Res Microbiol       Date:  1991-06       Impact factor: 3.992

10.  Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS.

Authors:  R D Arbeit; A Slutsky; T W Barber; J N Maslow; S Niemczyk; J O Falkinham; G T O'Connor; C F von Reyn
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  4 in total

1.  Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.

Authors:  M Picardeau; A Varnerot; T Lecompte; F Brel; T May; V Vincent
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  PCR-restriction enzyme analysis of a bone marrow isolate from a human immunodeficiency virus-positive patient discloses polyclonal infection with two Mycobacterium avium strains.

Authors:  R S Oliveira; M P Sircili; S Y Ueki; M A Telles; B Schnabel; M R Briones; S C Leão
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Characterization to species level of Mycobacterium avium complex strains from human immunodeficiency virus-positive and -negative patients.

Authors:  A M Kyriakopoulos; P T Tassios; P Matsiota-Bernard; E Marinis; S Tsaousidou; N J Legakis
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 4.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.